Role of Pharmacogenetics in Rational Development and Personalization of Drug Treatments

ISSN： 1741-0541

Source： Personalized Medicine, Vol.2, Iss.1, 2005-02, pp. : 13-14

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Challenges and opportunities of pharmacogenetics in drug development

By March Ruth

Personalized Medicine, Vol. 3, Iss. 2, 2006-05 ,pp. : 195-206

Future Medicine

Access to resources Recommend Favorite

Trial geography, pharmacogenetics, and global drug development

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 97, Iss. 3, 2015-03 ,pp. : 218-220

John Wiley & Sons Inc

Access to resources Recommend Favorite

Model‐Based Drug Development: A Rational Approach to Efficiently Accelerate Drug Development

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 93, Iss. 6, 2013-06 ,pp. : 502-514

John Wiley & Sons Inc

Access to resources Recommend Favorite

Structural Biology Toward Rational Drug Development in Collaboration with Molecular Imaging

Current Medical Imaging Reviews, Vol. 8, Iss. 4, 2012-01 ,pp. : 308-313

Bentham Science Publishers

Access to resources Recommend Favorite

A Question‐Based Approach to Adopting Pharmacogenetics to Understand Risk for Clinical Variability in Pharmacokinetics in Early Drug Development

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 96, Iss. 3, 2014-09 ,pp. : 291-295

John Wiley & Sons Inc

Access to resources Recommend Favorite